Scancell names development director
This article was originally published in Scrip
Executive Summary
Scancell, which develops immunotherapies for the treatment of cancer, has appointed Dr Sally Adams to its board of directors as development director – effective 1 May 2014. Dr Adams has worked as a consultant at Nottingham, UK-based Scancell since 2008. Previously, she was head of neurology and virology at British Biotech, and development director at Neures.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.